Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Lenvatinib exacerbates colitis by inhibiting intestinal vascular endothelial MAdCAM-1-mediated B cell trafficking.

ABSTRACT: The use of lenvatinib (Lenv) in advanced hepatocellular carcinoma (HCC) patients is associated with a range of adverse events, including gastrointestinal toxicities, yet the underlying mechanisms remain poorly understood. Here, we demonstrated that Lenv exacerbated both acute and chronic colitis in mouse models by impairing intestinal B cell homeostasis, leading to reduce intestinal B cells and plasma cells, along with decreased IL-10 and IgA secretion. Mechanistically, Lenv decreased MAdCAM-1 expression in intestinal vascular endothelial cells via the VEGFR/PLCγ/PKC/p65 signaling, thereby disrupting B cell homing to the gut. Notably, blockade of either p65 or MAdCAM-1 abrogated Lenv-induced B cell loss and colitis exacerbation. Furthermore, in both tumor-bearing mice and HCC patients receiving Lenv treatment, decreased serum sMAdCAM-1 levels correlated with reduced serum IgA and disruption of intestinal immune homeostasis. Thus, our results show a mechanism for Lenv disrupts intestinal immune homeostasis and implicate serum sMAdCAM-1 may serve as a potential biomarker for monitoring B cell-mediated intestinal immune dysfunction during Lenv therapy.

ORGANISM(S): Mus musculus

PROVIDER: GSE327105 | GEO | 2026/04/11

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Lenvatinib exacerbates colitis by inhibiting intestinal vascular endothelial MAdCAM-1-mediated B cell trafficking

Project description:The use of lenvatinib (Lenv) in advanced hepatocellular carcinoma (HCC) patients is associated with a range of adverse events, including gastrointestinal toxicities, yet the underlying mechanisms remain poorly understood. Here, we demonstrated that Lenv exacerbated both acute and chronic colitis in mouse models by impairing intestinal B cell homeostasis, leading to reduce intestinal B cells and plasma cells, along with decreased IL-10 and IgA secretion. Mechanistically, Lenv decreased MAdCAM-1 expression in intestinal vascular endothelial cells via the VEGFR/PLCγ/PKC/p65 signaling, thereby disrupting B cell homing to the gut. Notably, blockade of either p65 or MAdCAM-1 abrogated Lenv-induced B cell loss and colitis exacerbation. Furthermore, in both tumor-bearing mice and HCC patients receiving Lenv treatment, decreased serum sMAdCAM-1 levels correlated with reduced serum IgA and disruption of intestinal immune homeostasis. Thus, our results show a mechanism for Lenv disrupts intestinal immune homeostasis and implicate serum sMAdCAM-1 may serve as a potential biomarker for monitoring B cell-mediated intestinal immune dysfunction during Lenv therapy.

2026-04-11 | GSE327044 | GEO

Immunoglobulin A controls intestinal virus colonization to preserve immune homeostasis [ZE309]

Project description:Immunoglobulin A (IgA) is the predominant immunoglobulin isotype in mammals, primarily secreted at type I mucosal surfaces. Despite its abundance, the precise role of secretory IgA in the intestinal lumen, where it coats a diverse array of commensal microbiota, has remained elusive. Our study reveals that germinal center IgA responses are essential for preventing chronic colonization of the gut by specific viruses. In absence of IgA, chronic viral colonization triggers an antigen-driven expansion of CD8αβ+ intraepithelial lymphocytes (IELs). Although, these IELs are unable to clear the virus, they contribute to maintaining homeostasis by regulating its load and type-I interferon responses. Consequently, IgA deficiency increases susceptibility to colitis in genetically susceptible host or following chemical induction, but only in presence of viral pathobionts requiring IgA for their clearance. These findings underscore the potential vulnerability of IgA deficient individuals to immunopathology when exposed to selective viral pathobionts.

2025-03-24 | GSE289553 | GEO

Immunoglobulin A controls intestinal virus colonization to preserve immune homeostasis.

2025-03-24 | GSE289917 | GEO

Immunoglobulin A controls intestinal virus colonization to preserve immune homeostasis [ZE303]

2025-03-24 | GSE289554 | GEO

Neutrophil extracellular traps melt Peyer’s patches following stroke and myocardial infarction

Project description:Sterile tissue injury after stroke causes lymphocyte contraction in lymphoid tissues and may decrease circulating IgA-levels. Intestinal Peyer’s patches (PP) harbor large numbers of IgA+ B cell precursors and plasma cells. Whether and how tissue injury triggers PP-B cell death, thereby mediating IgA-loss, is unknown. We found decreased circulating IgA levels in stroke and myocardial infarction patients. Experimental stroke and myocardial infarction in mice phenocopied the human situation. Decreased plasma and fecal IgA were accompanied by rapid and macroscopic shrinkage of PP caused by substantial losses of PP-resident IgA+ precursors and plasma cells in mice. Tissue injury induced neutrophil activation endowed with the release of toxic neutrophil extracellular traps (NETs). Antibody-mediated or genetically- induced neutrophil loss, digestion of NETs, or inhibition of their release by the Gasdermin D blockade completely prevented lymphocyte loss and PP shrinkage. We also identified NETs in the plasma of stroke and myocardial infarction patients. Hence, tissue injury induces systemic NET-release, which might be targeted to maintain immune homeostasis at mucosal barriers.

2024-02-28 | PXD044644 | Pride

Peyer's Patch BCR repertoire analysis in mice lacking H2-Ab1 on intestinal epithelial cells

Project description:Intestinal epithelial cells (IEC) express large amounts of major histocompatibility complex II (MHCII) molecules. Despite this long-appreciated observation, the function of epithelial MHCII-mediated signaling on gut homeostasis remains enigmatic. As IECs serve as the primary cellular barrier between intestinal microbes and underlying host immune cells, we reasoned that IEC-intrinsic antigen presentation may play a role in tolerogenic responses towards the microbiota. Mice with an IEC-intrinsic defect in MHCII expression (IECΔMHCII) develop elevated T cell-dependent IgA responses, but a reduction in microbiota responsive regulatory T cells (Tregs). Despite elevated IgA levels in IECΔMHCII mice, immunoglobulin repertoires exhibit less selection and IgA has reduced reactivity to the microbiota, which is associated with increased inter-individual variability in microbiota composition. Consistent with reductions in microbiota-responsive Tregs, IECΔMHCII mice develop worsened colitis. A striking difference observed in the absence of IEC-MHCII is that while transcription of MHCII is similar, underlying mononuclear phagocytes had reduced surface MHCII. Macrophages were found to be capable of acquiring MHCII molecules from IECs, and macrophages isolated from IECΔMHCII mice had decreased capacity to stimulate Treg development. Thus, epithelial-myeloid interactions govern development of adaptive responses to microbial antigens within the gastrointestinal tract.

2021-09-09 | GSE183711 | GEO

Small intestinal immune cell distributions and transcriptomes in mice lacking H2-Ab1 on intestinal epithelial cells.

2021-09-09 | GSE183710 | GEO

CD45- EpCAM+ Intestinal Epithelial Cell Transcriptomes

2021-09-09 | GSE183709 | GEO

Distal Ileum Transcriptomes of Mice with DSS-colitis

2021-09-09 | GSE183708 | GEO

Selective induction of homeostatic Th17 cells in the murine intestine by cholera toxin interacting with the microbiota

Project description:Th17 cells play a role as an inflammation mediator in a variety of autoimmune disorders, including inflammatory bowel disease (IBD) and thus are widely considered to be pathogenic. However, Th17 cells are present in the normal intestine and show a homeostatic phenotype, i.e., they participate in the maintenance of intestinal homeostasis rather than inducing inflammation. We observed an enlarged Th17 population in the small intestine of C57BL/6.IgA-/- mice compared to wild-type mice, which was further amplified with cholera toxin (CT) immunization without causing intestinal inflammation. The increased Th17 induction and the correspondingly 10-fold higher CTB-specific serum IgG response in C57BL/6.IgA-/- mice after CT immunization was microbiota dependent and was associated with increased segmented filamentous bacteria (SFB) in the small intestine of C57BL/6.IgA-/- mice. Oral administration of vancomycin greatly dampened both CT immunogenicity and adjuvanticity, and the differential CT responses in IgA-/- and wild-type mice disappeared after intestinal microbiota equalization. Using gnotobiotic mouse models, we found that CT induction of homeostatic intestinal Th17 responses was supported not only by SFB but also by other commensal bacteria. Furthermore, transcriptome analysis using IL-17AhCD2 reporter mice revealed a similar gene expression profile in CT-induced intestinal Th17 cells and endogenous intestinal Th17 cells at homeostasis, with upregulated expressions of a panel of immune regulatory genes, which was distinctly different from the gene expression profile of pathogenic Th17 cells. Taken together, we identified a non-pathogenic signature of intestinal homeostatic Th17 cells, which are actively regulated by the commensal microbiota and can be selectively stimulated by CT.

2017-08-31 | GSE97571 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data